Skip to main content
. 2024 May 30;15(12):4007–4019. doi: 10.7150/jca.96168

Figure 6.

Figure 6

The potential targeting small molecule medicines of TBX3 in OS. (A) Genes with differential expression in primary OS and normal control samples were displayed using volcano maps. (B) Top five drugs most likely to target TBX3 in primary OS. (C) Genes with differential expression in metastatic OS and primary OS samples were displayed using volcano maps. (D) Top five drugs most likely to target TBX3 in metastatic OS. TBX3, T-box transcription factor 3; OS, osteosarcoma.